Clinical Trial Update: DC Vaccine in Colorectal Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial of a dendritic cell vaccine for colorectal cancer was terminated, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Dendritic cell vaccine

Snippet

Sponsor: University of Pennsylvania | Conditions: Colorectal Cancer | Phase 1 | Status: TERMINATED | Results posted: 2024-05-24